Bio-Techne shareholders vote to adopt Merck KGaA acquisition agreement at special meeting

Bitget2026/09/23 13:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Bio-Techne held a special shareholder meeting today to vote on its merger agreement with Merck KGaA, Darmstadt, Germany.
Shareholders approved and adopted the definitive merger agreement; the acquisition itself has not yet closed.
Closing remains targeted for late 2026 or early 2027, subject to remaining customary conditions and regulatory clearances.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Techne Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609230920PR_NEWS_USPR_____CG54646) on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Bio-Techne shareholders vote to adopt Merck KGaA acquisition agreement at special meeting

You may also like

Crypto prices